Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 5 Neoplasms 3 Vascular Diseases 2 Heart Diseases 2 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Neoplasms, Second Primary 1 Metabolic Diseases 1 Heart Failure 1 Drug-Related Side Effects and Adverse Reactions 1 Colorectal Cancer Metastatic 1 Cardiovascular Diseases 1 Cardiotoxicity 1 Cancer Therapy-related Cardiovascular Toxicity 1 Breast Neoplasms 1 Advanced Ovarian Cancer 1

Interventions

Oxaliplatin 5 Irinotecan 5 Panitumumab 4 Capecitabine 4 Bevacizumab 4 Cetuximab 3 Leucovorin 2 Fluorouracil 2 trifluridine tipiracil drug combination 1 spartalizumab 1 regorafenib 1 raltitrexed 1 pembrolizumab 1 camrelizumab 1 aflibercept 1 XELOX 1 Radiotherapy 1 Radiosurgery 1 Lycopene 1 Loperamide 1 Ethiodized Oil 1 Drug Therapy 1 Cytoreduction Surgical Procedures 1 Antineoplastic Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Colorectal Cancer Metastatic × Antineoplastic Agents × Clear all

NCT03923036 2019-04-22

AVOCETTE

University Hospital, Caen

Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡